pentavalent meningococcal vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pentavalent meningococcal vaccine, covering 2023-08-08 to 2023-08-08. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. [Phase 3]